Northwestern University researchers have developed the first selective therapy to prevent allergic reactions, which can range in severity from itchy hives and watery eyes to trouble breathing and even death.
Bio & Medicine
Jan 16, 2024
0
27
When cities transform into a colorful world of lights as darkness falls, it's often only possible to estimate their contours, which depending on the perspective can draw the attention to key details or trivia. In fluorescence ...
Optics & Photonics
Apr 13, 2022
0
766
A potential new treatment for mast cell cancers reduces the number of mast cells by "mutating" the messenger RNA (mRNA) before it can deliver instructions for manufacturing the gene responsible for cell proliferation. The ...
Molecular & Computational biology
Aug 10, 2021
0
373
The team at Culham Centre for Fusion Energy (CCFE) in South East England has notified the press that testing of plasma has begun on an upgrade to the Mega AMP Spherical Tokamak (MAST)—a new approach to creating a working ...
Human impacts on the environment are changing many biological responses, with effects on rare species and human health, but predicting such responses is complicated, according to a new paper by a University of Canterbury ...
Plants & Animals
Jun 24, 2020
0
93
In a recent study published in the Proceedings of the National Academy of Sciences (PNAS), University of California San Diego researchers moved one step closer to the ability to make heparin in cultured cells. Heparin is ...
Biotechnology
Apr 10, 2020
0
534
The Kepler spacecraft launched in 2009 with the goal of finding exoplanets orbiting distant stars. In the years since, astronomers have used Kepler observations to discover 2,818 exoplanets as well as another 2,679 exoplanet ...
Astronomy
Nov 2, 2018
1
811
Opioids have long been an important tool in the world of pain management, but the side effects of these drugs - from addiction and respiratory failure to severe itching and dizziness, can be overwhelming. Scientists have ...
Biochemistry
Mar 27, 2017
0
9
New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory ...
Biochemistry
Oct 9, 2013
0
0
Researchers at Duke University Medical Center have created synthetic nanoparticles that target lymph nodes and greatly boost vaccine responses, said lead author Ashley St. John, Ph.D., a researcher at Duke-NUS Graduate Medical ...
Bio & Medicine
Jan 22, 2012
0
0
